✦ LIBER ✦

Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia

✍ Scribed by Jeha, Sima; Coustan-Smith, Elaine; Pei, Deqing; Sandlund, John T.; Rubnitz, Jeffrey E.; Howard, Scott C.; Inaba, Hiroto; Bhojwani, Deepa; Metzger, Monika L.; Cheng, Cheng; Choi, John K.; Jacobsen, Jeffrey; Shurtleff, Sheila A.; Raimondi, Susana; Ribeiro, Raul C.; Pui, Ching-Hon; Campana, Dario

Book ID: 121733760
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 201 KB
Volume: 120
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.28598

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of tyrosine kinase inhibitors on

Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia

✍ Franz Gruber; Satu Mustjoki; Kimmo Porkka 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB

Tyrosine kinase inhibitors for the treat

Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia

✍ Pier Paolo Piccaluga; Stefania Paolini; Giovanni Martinelli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

## Abstract Acute lymphoblastic leukemia (ALL) is a heterogeneous disorder, with the greatest prevalence in children, but it also affects adults, and has an increasing incidence with age. Chromosomal abnormalities in ALL have been frequently described, the most common is the Philadelphia chromosome

Role of Tyrosine Kinase Inhibitors in th

Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

✍ Michael S. Mathisen; Susan O’Brien; Deborah Thomas; Jorge Cortes; Hagop Kantarji 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 152 KB

Effect of the Philadelphia chromosome on

Effect of the Philadelphia chromosome on minimal residual disease in acute lymphoblastic leukemia

✍ Brisco, M J; Sykes, P J; Dolman, G; Neoh, S-H; Hughes, E; Peng, L-M; Tauro, G; E 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 210 KB

Ponatinib: A New Tyrosine Kinase Inhibit

Ponatinib: A New Tyrosine Kinase Inhibitor for the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

✍ Shamroe, C. L.; Comeau, J. M. 📂 Article 📅 2013 🏛 Harvey Whitney Books Company 🌐 English ⚖ 288 KB

Allogeneic Transplantation for Ph+ Acute

Allogeneic Transplantation for Ph+ Acute Lymphoblastic Leukemia (ALL): Impact of Conditioning Intensity, Tyrosine Kinase Inhibitors (TKI) and Minimal Residual Disease (MRD)

✍ Bachanova, Veronika; Marks, David; Zhang, Mei-Jie; Wang, Hailin; Weisdorf, Danie 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB